Search Results

You searched for : HIV-1  

ViiV Healthcare and Medicines Patent Pool extends voluntary licensing agreement to enable access to long-acting injectable HIV treatment

It builds on the voluntary license for CAB LA for HIV pre-exposure prophylaxis (PrEP), enabling increased access to innovative long-acting injectables for HIV ...
Jul 15

The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening Infections

By focusing on these 17 high-priority pathogens, WHO is leading the way for a world that is better prepared, more resilient, and healthier for ...
Nov 09

Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study

Lungershausen said Avance Clinical is focussed on accelerating drug development for its biotech clients, from preclinical stages through to Phase III....
Mar 29

Coronavirus vs. Human immunodeficiency virus - Medicircle

Know the major difference between the Coronavirus (COVID-19) and Human Immunodeficiency Virus (HIV). Furthermore, learn about the ways in which one can protect themselves ...
Mar 29

ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe

Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV...
Jan 15

ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay

...
Jan 13

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ...
Dec 21

ViiV Healthcare announces positive CHMP opinion for Rukobia, for the treatment of adults with multidrug-resistant HIV

Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left....
Dec 11

Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1

Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option with Focus on Women...
Nov 16

ViiV Healthcare announces CHMP positive opinion for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe

Dolutegravir is the first integrase inhibitor available as a dispersible tablet for children...
Nov 13

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

ViiV Healthcare announced CHMP issed positive opinion recommending Vocabria in combination with Rekambys and Edurant for the treatment of HIV-1 ...
Oct 16

GSK's Dovato holds against Tenofavir Alafenamide Fumarate for HIV1 patients

GSK two drug combination is as good as 3 drug regimen which is presently continued for HIV 1 patients...
Oct 09

Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir With Doravirine for HIV-1

Merck, today announced Week 96 data from the Phase 2b trial evaluating the efficacy and safety of islatravir for HIV-1 infections...
Oct 08

ViiV Healthcare announces dolutegravir plus lamivudine for treatment-naïve adults with HIV-1

Findings showed that the 2-drug regimen (2DR) of dolutegravir plus lamivudine continued to offer non-inferior efficacy...
Oct 05

ViiV Healthcare to present long-term safety and efficacy data for 2-drug regimen

Data presented may shift the treatment paradigm to 2-drug regimens (2DRs) for people living with HIV ...
Oct 01

USFDA approves Roche's Cobas 6800/8800 systems also for HIV Tests

Cobas 6800/8800 gets USFDA approval for the machines are also being used in India for Covid detection...
Sep 05

ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV

CABENUVA reduces treatment dosing days from 365 to 12 per year ​...
Mar 21

A new strain of HIV infection found after about 20 years

New starin of HIV detected...
Jan 25

18 Matching result(s) found!

-Advertisements-




Trending Now

Gulf Medical University Ranks 1st for International Student Ratio in QS Arab Region Rankings 2027October 22, 2026
Arthritis Is Not Just an Elderly Person's Disease: Why Younger Adults Are Also Developing Joint ProblemsOctober 22, 2026
Krishna Automotive strengthens its operations in Hyderabad. Enhances customer offering with BMW Service Workshop and BMW Premium Selection.October 22, 2026
CTR-JK Tyre FMSCI Indian National Car Racing Championship 2026 set for season opener in CoimbatoreOctober 22, 2026
The Anonymous Indian Charitable Trust (TAICT) Wins Sustainable Organization Award 2026October 22, 2026
Vinod Intelligent Cookware Targets Delhi’s Premium Cookware Market with Freya Brand ActivationOctober 22, 2026
Apollo Hospitals and Avadi Police Commissionerate Organise Health Camp for Police Personnel and Their Families Under ‘Kaval Kudumbam’ SchemeOctober 22, 2026
TAMPOS Midterm Conference 2026 Brings Together 150 Oncologists to Advance Cancer Care Across Tamil NaduOctober 22, 2026
Shades of Pink: Apollo Athenaa Women's Cancer Centres puts the spotlight on breast health awarenessOctober 22, 2026
How Health Systems Can Reduce Missed Follow-UpsOctober 21, 2026
What Good Care Coordination Looks Like Across Multiple ProvidersOctober 21, 2026
The Growing Role of Home-Based Care in Healthcare DeliveryOctober 19, 2026
How Rehabilitation Teams Contribute to Long-Term Recovery PlanningOctober 19, 2026
How Rehabilitation Teams Contribute to Long-Term Recovery PlanningOctober 19, 2026
Why Nutrition Counselling Belongs in Integrated CareOctober 17, 2026
How Medical Social Work Connects Patients With Support ServicesOctober 17, 2026
Wearable Biosensors: Future of Continuous Health MonitoringOctober 17, 2026
Needle-Free Diagnostics: The Future of Blood TestingOctober 17, 2026
Patient Privacy and AI in Indian Healthcare TodayOctober 16, 2026
Healthcare Cyber Drills: Should Hospitals Rehearse for Digital Disasters?October 16, 2026